Question 1

Does BlackRock own ABT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 152,563,476 shares of ABT (Abbott Laboratories), worth $13.8B.

Question 2

How many shares of ABT does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 152,563,476 shares of ABT (Abbott Laboratories).

Question 3

What is BlackRock's ABT position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's ABT position is worth $13.8B.

Question 4

Is BlackRock buying or selling ABT?

Accepted Answer

In Q2 2026, BlackRock increased its ABT position by 6,876,018 shares (+4.7%).

Question 5

When did BlackRock first buy ABT?

Accepted Answer

BlackRock already held ABT in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	152.6M	+4.7%	$13.8B	0.2%	$89.55	40
2026-Q1	Decreased	145.7M	-0.8%	$15B	0.3%	$100.69	0
2025-Q4	Increased	146.9M	+3.8%	$18.4B	0.3%	$122.25	40
2025-Q3	Increased	141.6M	+0.2%	$19B	0.3%	$130.11	38
2025-Q2	Increased	141.3M	+3.1%	$19.2B	0.4%	$131.53	39
2025-Q1	Increased	137M	+0.3%	$18.2B	0.4%	$127.69	38
2024-Q4	Increased	136.5M	+4.2%	$15.4B	0.3%	$108.31	40
2024-Q3	First report	131M	-	$14.9B	0.3%	$108.66	0

ABT8 quarters

ABT
8 quarters